268 related articles for article (PubMed ID: 16619563)
21. A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions.
Wang X; Zhou J; Wang Y; Zhu Z; Lu Y; Wei Y; Chen L
Eur J Cancer; 2010 May; 46(8):1474-80. PubMed ID: 20207133
[TBL] [Abstract][Full Text] [Related]
22. [Two cases of malignant effusion treated successfully by loco-regional administration of carboplatin].
Takahashi J; Kinomura S; Abe Y; Yoshioka S; Yambe T; Ono S; Ito H; Fukuda H; Yamada K; Sato T
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2817-20. PubMed ID: 7993120
[TBL] [Abstract][Full Text] [Related]
23. [Adhesion therapy for malignant pleural effusion (intrapleural administration of OK-432 with minocycline)].
Tanaka A; Sato T
Nihon Kokyuki Gakkai Zasshi; 1999 Jul; 37(7):531-7. PubMed ID: 10481458
[TBL] [Abstract][Full Text] [Related]
24. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions.
Kishi K; Homma S; Sakamoto S; Kawabata M; Tsuboi E; Nakata K; Yoshimura K
Eur Respir J; 2004 Aug; 24(2):263-6. PubMed ID: 15332395
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study of intrapleural administration of pirarubicin (THP-ADM) in the treatment of malignant pleural effusion secondary to lung cancer].
Makimoto T; Hoshino H; Tsuchiya S; Nakano H; Watanabe S; Naruse I; Fueki N; Ezawa K; Takise A; Saitoh R
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1542-7. PubMed ID: 8121090
[TBL] [Abstract][Full Text] [Related]
26. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K
Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209
[TBL] [Abstract][Full Text] [Related]
27. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
[TBL] [Abstract][Full Text] [Related]
28. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
Luh KT; Yang PC; Kuo SH; Chang DB; Yu CJ; Lee LN
Cancer; 1992 Feb; 69(3):674-9. PubMed ID: 1309678
[TBL] [Abstract][Full Text] [Related]
29. Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial.
Seto T; Ushijima S; Yamamoto H; Ito K; Araki J; Inoue Y; Semba H; Ichinose Y;
Br J Cancer; 2006 Sep; 95(6):717-21. PubMed ID: 16940982
[TBL] [Abstract][Full Text] [Related]
30. [Two patients of recurrent breast cancer with carcinomatous pleurisy well controlled pleural effusion].
Hojo S; Maeura Y; Fukunaga H; Yoshioka S; Ota H; Endo W; Yamazaki K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1795-7. PubMed ID: 16315944
[TBL] [Abstract][Full Text] [Related]
31. Inhalation therapy using a streptococcal preparation (OK-432) against bronchioloalveolar carcinoma of the lung.
Yano T; Ichinose Y; Yokoyama H; Fukuyama Y; Sugio K; Sugimachi K
Anticancer Res; 1999; 19(6C):5511-4. PubMed ID: 10697608
[TBL] [Abstract][Full Text] [Related]
32. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
Charoentum C; Thongprasert S; Chewasakulyong B
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374
[TBL] [Abstract][Full Text] [Related]
34. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Kondo H; Yamamoto K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
[TBL] [Abstract][Full Text] [Related]
35. Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.
Nio Y; Nagami H; Tamura K; Tsubono M; Nio M; Sato M; Kawabata K; Hayashi H; Shiraishi T; Imai S; Tsuchitani T; Mizuta J; Nakagawa M; Fukumoto M
Br J Cancer; 1999 May; 80(5-6):775-85. PubMed ID: 10360655
[TBL] [Abstract][Full Text] [Related]
36. Histological effect of intranodal injection of the streptococcal preparation OK-432 for cervical lymph node metastases of malignant head and neck tumors.
Suzuki K; Tsuge I; Ito Y; Kunii H; Baba S
Acta Otolaryngol Suppl; 1996; 525():125-8. PubMed ID: 8908286
[TBL] [Abstract][Full Text] [Related]
37. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
38. Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.
Blumenschein GR; Gatzemeier U; Fossella F; Stewart DJ; Cupit L; Cihon F; O'Leary J; Reck M
J Clin Oncol; 2009 Sep; 27(26):4274-80. PubMed ID: 19652055
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
Schiller JH; Larson T; Ou SH; Limentani S; Sandler A; Vokes E; Kim S; Liau K; Bycott P; Olszanski AJ; von Pawel J
J Clin Oncol; 2009 Aug; 27(23):3836-41. PubMed ID: 19597027
[TBL] [Abstract][Full Text] [Related]
40. [Pleuritis carcinomatosa].
Miyanaga A; Gemma A
Gan To Kagaku Ryoho; 2011 Apr; 38(4):524-7. PubMed ID: 21498978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
